Protection Against Type 1 Diabetes Development in Mice with 4E-BP2 Deletion

Authors:

Abstract
Type 1 diabetes (T1D) is an autoimmune disease characterized by β-cell destruction promoted by autoreactive T cells. 4E-BP1/2 proteins are translational repressors and downstream targets of mTORC1. Activation of 4E-BP2/eIF4E pathway by 4E-BP2 deletion promotes translation initiation, inducing β-cell expansion and proliferation and regulating adaptive immunity. However, the involvement of 4E-BP2 in T1D remains unexplored. This study aimed to determine the role of 4E-BP2/eIF4E signaling in T1D prevention. We used the non-obese diabetic (NOD) mouse model of T1D, and generated mice with global 4E-BP2 deletion in the NOD background (Eif4epb2-/-). We assessed T1D development, glucose homeostasis, pancreas morphometry and immune responses in Eif4epb2-/- and littermate control mice. We found that Eif4epb2-/- male mice exhibited reduced diabetes incidence, which did not occur in female mice, and was associated with preserved β-cell mass, improved insulin secretion in vitro, and comparable insulitis. Characterization of T cell compartments showed decreased splenic CD8+ cytotoxic T cell proliferation and increased pancreatic regulatory T cell infiltration in Eif4epb2-/- mice, potentially due to increased proliferation and suppressive capacity. Adoptive transfer studies demonstrated that Eif4epb2-/- male lymphocytes were less diabetogenic than controls. Overall, activation of 4E-BP2/eIF4E by 4E-BP2 deletion protects against T1D, identifying 4E-BP2 as a potential therapy target.
All Related Versions
  • Published version: .